Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 3/6 |
Past Performance | 6/6 |
Financial Health | 6/6 |
Dividends | 4/6 |
7741 Stock Overview
HOYA Corporation operates as a med-tech company, and a supplier of high-tech and medical products worldwide.
Rewards
Risk Analysis
No risks detected for 7741 from our risk checks.
HOYA Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | JP¥13,395.00 |
52 Week High | JP¥19,435.00 |
52 Week Low | JP¥12,020.00 |
Beta | 0.63 |
1 Month Change | 3.44% |
3 Month Change | -10.34% |
1 Year Change | -8.66% |
3 Year Change | 72.00% |
5 Year Change | 145.78% |
Change since IPO | 2,415.49% |
Recent News & Updates
Shareholder Returns
7741 | JP Medical Equipment | JP Market | |
---|---|---|---|
7D | 5.1% | -0.2% | 0.7% |
1Y | -8.7% | -7.6% | -2.9% |
Return vs Industry: 7741 underperformed the JP Medical Equipment industry which returned -7.6% over the past year.
Return vs Market: 7741 underperformed the JP Market which returned -2.9% over the past year.
Price Volatility
7741 volatility | |
---|---|
7741 Average Weekly Movement | 5.8% |
Medical Equipment Industry Average Movement | 4.3% |
Market Average Movement | 4.6% |
10% most volatile stocks in JP Market | 9.1% |
10% least volatile stocks in JP Market | 2.5% |
Stable Share Price: 7741 is not significantly more volatile than the rest of JP stocks over the past 3 months, typically moving +/- 6% a week.
Volatility Over Time: 7741's weekly volatility (6%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1941 | 37,245 | Eiichiro Ikeda | https://www.hoya.co.jp |
HOYA Corporation operates as a med-tech company, and a supplier of high-tech and medical products worldwide. The company operates through three segments: Life Care, Information Technology, and Other. The Life Care segment offers healthcare products, including eyeglass and contact lenses; and medical products, such as medical endoscopes, laparoscopic surgical instruments, intraocular lenses, and prosthetic ceramic fillers and orthopedic implants.
HOYA Fundamentals Summary
7741 fundamental statistics | |
---|---|
Market Cap | JP¥4.85t |
Earnings (TTM) | JP¥164.51b |
Revenue (TTM) | JP¥661.47b |
29.7x
P/E Ratio7.4x
P/S RatioIs 7741 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
7741 income statement (TTM) | |
---|---|
Revenue | JP¥661.47b |
Cost of Revenue | JP¥293.67b |
Gross Profit | JP¥367.80b |
Other Expenses | JP¥203.29b |
Earnings | JP¥164.51b |
Last Reported Earnings
Mar 31, 2022
Next Earnings Date
n/a
Earnings per share (EPS) | 450.63 |
Gross Margin | 55.60% |
Net Profit Margin | 24.87% |
Debt/Equity Ratio | 2.7% |
How did 7741 perform over the long term?
See historical performance and comparisonDividends
1.0%
Current Dividend Yield25%
Payout RatioValuation
Is HOYA undervalued compared to its fair value and its price relative to the market?
Valuation Score
0/6Valuation Score 0/6
Below Fair Value
Significantly Below Fair Value
PE vs Industry
PE vs Market
PEG Ratio
PB vs Industry
29.73x
Price to Earnings (PE) ratio
Share Price vs. Fair Value
Below Fair Value: 7741 (¥13395) is trading above our estimate of fair value (¥13394.11)
Significantly Below Fair Value: 7741 is trading above our estimate of fair value.
Price To Earnings Ratio
PE vs Industry: 7741 is poor value based on its PE Ratio (29.7x) compared to the JP Medical Equipment industry average (13.7x).
PE vs Market: 7741 is poor value based on its PE Ratio (29.7x) compared to the JP market (12.2x).
Price to Earnings Growth Ratio
PEG Ratio: 7741 is poor value based on its PEG Ratio (3.7x)
Price to Book Ratio
PB vs Industry: 7741 is overvalued based on its PB Ratio (6.1x) compared to the JP Medical Equipment industry average (1.4x).
Future Growth
How is HOYA forecast to perform in the next 1 to 3 years based on estimates from 14 analysts?
Future Growth Score
3/6Future Growth Score 3/6
Earnings vs Savings Rate
Earnings vs Market
High Growth Earnings
Revenue vs Market
High Growth Revenue
Future ROE
8.0%
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 7741's forecast earnings growth (8% per year) is above the savings rate (0.02%).
Earnings vs Market: 7741's earnings (8% per year) are forecast to grow slower than the JP market (8.8% per year).
High Growth Earnings: 7741's earnings are forecast to grow, but not significantly.
Revenue vs Market: 7741's revenue (6% per year) is forecast to grow faster than the JP market (4% per year).
High Growth Revenue: 7741's revenue (6% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: 7741's Return on Equity is forecast to be high in 3 years time (24.7%)
Past Performance
How has HOYA performed over the past 5 years?
Past Performance Score
6/6Past Performance Score 6/6
Quality Earnings
Growing Profit Margin
Earnings Trend
Accelerating Growth
Earnings vs Industry
High ROE
10.0%
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: 7741 has high quality earnings.
Growing Profit Margin: 7741's current net profit margins (24.9%) are higher than last year (22.9%).
Past Earnings Growth Analysis
Earnings Trend: 7741's earnings have grown by 10% per year over the past 5 years.
Accelerating Growth: 7741's earnings growth over the past year (31.1%) exceeds its 5-year average (10% per year).
Earnings vs Industry: 7741 earnings growth over the past year (31.1%) exceeded the Medical Equipment industry 17.4%.
Return on Equity
High ROE: 7741's Return on Equity (21%) is considered high.
Financial Health
How is HOYA's financial position?
Financial Health Score
6/6Financial Health Score 6/6
Short Term Liabilities
Long Term Liabilities
Debt Level
Reducing Debt
Debt Coverage
Interest Coverage
Financial Position Analysis
Short Term Liabilities: 7741's short term assets (¥683.0B) exceed its short term liabilities (¥147.4B).
Long Term Liabilities: 7741's short term assets (¥683.0B) exceed its long term liabilities (¥56.4B).
Debt to Equity History and Analysis
Debt Level: 7741 has more cash than its total debt.
Reducing Debt: 7741's debt to equity ratio has reduced from 7.1% to 2.7% over the past 5 years.
Debt Coverage: 7741's debt is well covered by operating cash flow (879.9%).
Interest Coverage: 7741 earns more interest than it pays, so coverage of interest payments is not a concern.
Balance Sheet
Dividend
What is HOYA current dividend yield, its reliability and sustainability?
Dividend Score
3/6Dividend Score 3/6
Notable Dividend
High Dividend
Stable Dividend
Growing Dividend
Earnings Coverage
Future Dividend Coverage
0.97%
Current Dividend Yield
Dividend Yield vs Market
Notable Dividend: 7741's dividend (0.97%) isn’t notable compared to the bottom 25% of dividend payers in the JP market (1.64%).
High Dividend: 7741's dividend (0.97%) is low compared to the top 25% of dividend payers in the JP market (3.7%).
Stability and Growth of Payments
Stable Dividend: 7741's dividends per share have been stable in the past 10 years.
Growing Dividend: 7741's dividend payments have increased over the past 10 years.
Earnings Payout to Shareholders
Earnings Coverage: With its low payout ratio (24.6%), 7741's dividend payments are well covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: With its reasonably low cash payout ratio (29.4%), 7741's dividend payments are well covered by cash flows.
Discover strong dividend paying companies
Management
How experienced are the management team and are they aligned to shareholders interests?
8.0yrs
Average management tenure
CEO
Eiichiro Ikeda (51 yo)
8.92yrs
Tenure
JP¥112,000,000
Compensation
Mr. Eiichiro Ikeda serves as Representative Executive Officer and Chief Executive Officer at Hoya Corp. since March 1, 2022 and serves as its President since March 1, 2022 and served as Chief Technology Of...
CEO Compensation Analysis
Compensation vs Market: Eiichiro's total compensation ($USD875.95K) is below average for companies of similar size in the JP market ($USD1.60M).
Compensation vs Earnings: Eiichiro's compensation has been consistent with company performance over the past year.
Leadership Team
Experienced Management: 7741's management team is seasoned and experienced (8 years average tenure).
Board Members
Experienced Board: 7741's board of directors are considered experienced (7.9 years average tenure).
Ownership
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Top Shareholders
Company Information
HOYA Corporation's employee growth, exchange listings and data sources
Key Information
- Name: HOYA Corporation
- Ticker: 7741
- Exchange: TSE
- Founded: 1941
- Industry: Health Care Supplies
- Sector: Healthcare
- Implied Market Cap: JP¥4.846t
- Shares outstanding: 365.06m
- Website: https://www.hoya.co.jp
Number of Employees
Location
- HOYA Corporation
- Nittochi Nishishinjuku Building
- 20th Floor
- Tokyo
- 160-8347
- Japan
Listings
Company Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2022/05/23 00:00 |
End of Day Share Price | 2022/05/23 00:00 |
Earnings | 2022/03/31 |
Annual Earnings | 2022/03/31 |
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.